The same affected sponge component appears in five types of procedure kit. Hospitals therefore need to locate finished kits across specialties and remove the component as directed, while distributors pass the notice to downstream customers.
Device Recalls · FDA Class II Recall Watch: 30 August–5 September 2026 ·
A supplier packaging defect can propagate through many downstream procedure-kit configurations, creating substantial traceability and relabeling work for hospitals and distributors. The event also illustrates an important quantity-handling edge case: an identical event total repeated across multiple FDA records should not be summed as though each were a separate quantity.
Device Recalls · FDA Class II Recall Watch: 16–22 August 2026 ·
These circuits support neonatal and infant respiratory care, so a connector failure can create both immediate clinical-management needs and broad inventory work. The recall also illustrates how one failure mode may span several FDA product classifications and catalog families while still representing a single underlying field action.
Device Recalls · FDA Class II Recall Watch: 16–22 August 2026 ·
The event shows how one component-level nonconformance can propagate into many finished surgical-kit configurations and product classifications. For hospitals and manufacturers, the response depends on tracing affected kits, quarantining inventory, applying warning over-labels, removing the affected component before kit use, and notifying downstream customers when products were redistributed.
FDA has classified the recall of certain Medline convenience kits containing B. Braun bupivacaine hydrochloride components as Class I. Medline Industries, LP is correcting affected kits because they include Huons Bupivacaine Hydrochloride in Dextrose Injection, USP that was recalled for quality issues.